Introduction {#Sec1}
============

A large prospective cohort study by the Taiwan National Institutes of Health in 2008 reported that nearly 2.3 million people in Taiwan (12% of the population) have chronic kidney disease (CKD)^[@CR1]^. When CKD progresses to end-stage renal disease (ESRD), patients require long-term dialysis to sustain life. The medical care system in Taiwan is a single-payer compulsory insurance program. The medical expenditures related to hemodialysis (HD) have increased because of an increase in the number of HD patients over the past few decades^[@CR2]^. Therefore, monitoring the quality of HD and reducing the complication rate in HD patients have become important concerns that should be addressed to contain medical costs in health care systems.

HD requires vigorous quality control to ensure patient safety and provide high quality care^[@CR3]^. Electronic information technology can provide potential benefits in health-care management^[@CR4]^. Moreover, aggressive application electronic information technology in the health care industry, referred to as e-interventions, has become a global trend in recent years, and is considered as a necessary tool for providing high quality care^[@CR5]^. The e-interventions has been managed the vast clinical data of HD patients^[@CR6],\ [@CR7]^, thus improving the quality of medical care^[@CR8],\ [@CR9]^.

The present study evaluated the effects of e-interventions on the quality of medical care, particularly on the 4-year all-cause mortality rate, among HD patients in the largest medical system in Taiwan.

Results {#Sec2}
=======

Demographic and clinical characteristics of the study groups and the final outcomes {#Sec3}
-----------------------------------------------------------------------------------

The mean age of the 600 study patients was 59 years (25--87 years), with a similar male-female distribution (52% vs. 48%). More patients with an education level below junior high school (relatively low education level) were observed in the e-intervention group (74%) than in the non-e-intervention group (65.67%). More patients were married in the e-intervention group (72%) than in the non-e-intervention group (39.33%). Regarding HD vintage, the duration of HD in the e-intervention and non-e-intervention groups was 1--28 years. Chronic glomerulonephritis was the most frequent cause of ESRD in the non-e-intervention group (49.67%), and hypertension was the major cause of ESRD in the e-intervention group (37.67%). More patients had hepatitis B virus infections in the e-intervention group (17%) than in the non-e-intervention group (6.67%). Before the e-intervention, the two study groups differed significantly in their proportion of anuria, haematocrit levels, blood sugar levels, proportion of iron supply, monthly erythropoietin usage, and cardiothoracic ratio. Regarding the outcome variables, the e-intervention group had significantly fewer hospitalization days than the non-e-intervention group at 1-year post e-intervention (Table [1](#Tab1){ref-type="table"}). The causes of death during the study period and the mortality rates are shown in Table [1](#Tab1){ref-type="table"}. The e-intervention group had a relatively lower 4-year all-cause mortality rate than the non-e-intervention group.Table 1Demographic factors and clinical characteristics of the study patients.VariablesAll (n = 600) Frequency (%)/Mean ± SDNon-e group (n = 300) Frequency (%)/Mean ± SDe group (n =300) Frequency (%)/Mean ± SDp value**Basic demographicsAge (years)**58.96 ± 1159.04 ± 11.1558.88 ± 10.860.8641**Sex**Male312 (52.00)156 (52.00)156 (52.00)1.0000Female288 (48.00)144 (48.00)144 (48.00)**Education level**Under junior high school419 (69.83)197 (65.67)222 (74.00)0.0328Senior high school and above181 (30.17)103 (34.33)78 (26.00)**Occupation**Laborer65 (10.83)34 (11.3)31 (10.3)0.9245Non-laborer111 (18.50)55 (18.3)56 (18.7)Unemployed424 (70.67)211 (70.3)213 (71.0)**Marital status**Married334 (55.67)118 (39.33)216 (72.00)\<0.0001**Body mass index (kg/m** ^**2**^ **)**22.56 ± 3.422.4 ± 3.5522.86 ± 3.10.1808**Medical characteristics and co-morbiditiesDuration of HD (years)**7.19 ± 5.297.16 ± 5.317.22 ± 5.280.9019**The cause of end-stage renal disease**CGN258 (43.00)149 (49.67)109 (36.33)\<0.0001Diabetes mellitus123 (20.50)60 (20.00)63 (21.00)Hypertension155 (25.83)42 (14.00)113 (37.67)Others64 (10.67)15 (16.33)15 (5.00)**Co-morbiditiesHBV antigen**Positive71 (11.83)20 (6.67)51 (17.00)\<0.0001**HCV antibody**Positive96 (16.00)51 (17.00)45 (15.00)0.5039**Diabetes mellitus**Yes120 (20.00)60 (20.00)60 (20.00)1.0000**Hypertension**Yes202 (33.67)101 (33.67)101 (33.67)1.0000**Vascular access type**A-V fistula454 (75.67)225 (75.00)229 (76.33)0.4248A-V graft121 (20.17)65 (21.67)56 (18.67)Double lumen catheter\^25 (4.17)10 (3.33)15 (5.00)**Physiological and biochemical variables before the e-intervention**Yes542 (90.33)260 (86.67)282 (94.00)0.0021Surface area of the dialyzer (m^2^)1.96 ± 0.291.98 ± 0.281.94 ± 0.30.1484Blood flow (mL/min)288.18 ± 40.04285.67 ± 36.91290.7 ± 42.860.1238Albumin (g/dL)3.95 ± 0.343.93 ± 0.343.97 ± 0.340.1892Pre-HD creatinine (mg/dL)10.64 ± 2.3410.54 ± 2.3510.74 ± 2.330.3254nPCR (g/kg/day)1.26 ± 0.381.25 ± 0.371.26 ± 0.390.9166TACurea (mg/dL)41.55 ± 10.9241.21 ± 10.9541.86 ± 10.90.4758Potassium (meq/L)4.92 ± 0.724.97 ± 0.714.88 ± 0.720.1469Kt/V1.79 ± 0.321.79 ± 0.351.8 ± 0.290.6175URR0.77 ± 0.060.77 ± 0.060.76 ± 0.070.1877Hematocrit (Hct, %)31.86 ± 4.0932.2 ± 4.131.52 ±4.060.0436Iron administration by veinYes124 (20.67)42 (14.00)82 (27.33)\<0.0001Monthly EPO usage (1000U/month)\*16 (8, 22)16 (8, 22)18 (11, 22)0.0090Calcium (mg/dL)9.67 ± 0.949.64 ± 0.939.71 ± 0.950.4001Phosphate (mg/dL)4.71 ± 1.374.63 ± 1.334.79 ± 1.410.1679iPTH (ng/mL)\*134.15138.3127.30.6062(49.9, 312.15)(49.9, 324.2)(50, 288.3)Total cholesterol (mg/dL)174.9 ± 37.59172.3 ± 36.94177.39 ± 38.10.1064Glucose (mg/dL)\*97 (85, 132)99.5 (87,133.5)95 (82, 129)0.0277Cardiothoracic ratio0.49 ± 0.060.5 ± 0.070.48 ± 0.06\<0.0001**Outcome variables**Total length of hospitalization (days/person-year)1.63 ± 8.993.26 ± 12.510 ± 0\<0.0001**4-year all-cause mortality n(%)**Deaths105 (17.50)59 (19.67)46 (15.33)0.1620Survivors495 (82.50)241 (80.33)254 (84.67)Cause of death n (%)Gastro-entero-intestine (GI)14 (10.37)8 (10.81)6 (9.84)0.5890Cardiovascular Diseases (CVDs)37 (27.41)18 (24.32)19 (31.15)Infections76 (56.30)42 (56.76)34 (55.74)Others (including injuries, lung diseases, etc)8 (5.93)6 (8.11)2 (3.28)e group: e-intervention group; non-e group: non-e-intervention group; HD: hemodialysis; CGN: chronic glomerulonephritis; HBV: hepatitis B virus; HCV: hepatitis C virus; A-V: arteriovenous; nPCR: normalized protein catabolic rate; TACurea: time-averaged concentration of urea; URR: urea reduction ratio; EPO: erythropoietin; iPTH: intact parathyroid hormone.\^ Double lumen catheter includes tunneled cuffed catheter\*The variables with skew distribution were presented as median (1st-quartile, 3rd-quartile) and tested with Mann-Whitney U-test accordingly.

Statistical analysis results for e-intervention effects {#Sec4}
-------------------------------------------------------

In multivariable Cox regression analysis, patients in the non-e-intervention group (hazard ratio \[HR\] = 1.991; 95% confidence interval \[CI\] = 1.194\~3.317) were more likely to die within the 4-year follow-up period than those in the e-intervention group, after adjusting for other variables based on the model selection criteria. In addition, significantly higher mortality rates were observed in patients with a relatively lower education level, unmarried patients, those with lower pre-HD serum creatinine levels, and those with higher sugar levels (Table [2](#Tab2){ref-type="table"}). Stratified analysis revealed significant differences in the serum albumin levels, urea reduction ratio (URR), cardiothoracic ratio and HD blood flow rate of the e-intervention and non-e-intervention groups at 1-year follow-up. The e-intervention group had higher serum albumin levels (3.97 vs. 3.90 g/dL, *p* = 0.0041), a higher URR (0.78 vs. 0.76, *p* \< 0.0001), a lower cardiothoracic ratio (0.48 vs. 0.50, *p* \< 0.0001), and a faster HD blood flow rate (291 vs. 284 mL/min, *p* = 0.0032) than the non-e-intervention group (Table [3](#Tab3){ref-type="table"}). Kaplan-Meier survival curve analysis demonstrated that the e-intervention group had a significantly lower 2-year all-cause mortality rate than the non-e-intervention group (Figure [1](#Fig1){ref-type="fig"}).Table 2Factors associated with 4-year all-cause mortality of the hemodialysis patients.VariablesPerson-monthsNumber of deathUnivariate measureMultivariate-adjusted measureHR95%CIHR95%CI**Study groups**Non-e-intervention12880.8651.264(0.881, 1.813)1.991\*(1.194, 3.317)e-intervention13442.554------------**Basic demographicsEducation level**Under junior high school17977.51043.267\*(1.901, 5.615)1.913\*(1.012, 3.616)Senior high school and above8345.815------------**Occupation**Laborer3076.04------Non-laborer5070.4162.438(0.815, 7.293)Unemployment18177.0994.274\*(1.573, 11.613)**Marital status**Married13706.116------------Not married12617.21036.125\*(3.616,10.375)5.500\*(2.934, 10.311)**Body mass index (each increment)**------0.981(0.926, 1.039)**Disease characteristics and co-morbiditiesDuration of HD (years)**------0.973(0.939, 1.009)**Co-morbiditiesHBV antigen**Negative23076.8109------------Positive3246.4100.647(0.339, 1.237)1.246(0.598, 2.598)**HCV antibody**Negative22017.797------Positive4305.5221.153(0.726, 1.832)**Diabetes mellitus**No21570.870------Yes4752.5493.271\*(2.269, 4.715)**Hypertension**No17324.581------Yes8998.8380.900(0.612, 1.324)**Vascular access type**A-V fistula20119.375------------A-V graft5252.0311.596\*(1.050, 2.425)1.589(0.953, 2.649)Double lumen catheter952.0133.822\*(2.119, 6.894)1.975(0.952, 4.095)**Physiological and biochemical variables before the e-intervention**Daily urine amount (mL/day)------0.970\*(0.949, 0.992)Surface area of the dialyzer (m^2^)------1.316(0.695, 2.491)Albumin (g/dL)------0.249\*(0.150, 0.414)0.771(0.356, 1.669)Pre-HD creatinine (mg/dL)------0.748\*(0.686, 0.815)0.813\*(0.708, 0.933)nPCR (g/kg/day)------0.452\*(0.257, 0.794)TACurea (mg/dL)------0.963\*(0.946, 0.981)Potassium (meq/L)------0.647\*(0.497, 0.843)Kt/V------0.881(0.499, 1.555)URR------2.572(0.153, 43.341)4.251(0.132, 136.648)Hematocrit (%)------0.963(0.920, 1.008)1.034(0.956, 1.117)Iron supplyNo20830.591------------Yes5492.8281.166(0.763, 1.781)1.274(0.780, 2.081)Monthly EPO usage (1000U/month)------1.016(0.995, 1.037)1.010(0.981, 1.041)Calcium (mg/dL)------0.856(0.701, 1.047)Phosphate (mg/dL)------0.836\*(0.727, 0.961)1.107(0.918, 1.334)iPTH (ng/mL)------0.999(0.999, 1.000)Total cholesterol (mg/dL)------0.991\*(0.985, 0.996)0.994(0.987, 1)Cardiothoracic ratio------555.934\*(41.821, 7390.177)28.888(0.818, 1020.780)Glucose (mg/dL)------1.004\*(1.003, 1.006)1.003\*(1.001, 1.005)Blood flow (cc/min)------0.989\*(0.984, 0.993)1.002(0.994, 1.009)AnuriaNo2778.51------------Yes23544.811814.197\*(1.984, 101.596)6.031(0.809, 44.966)Hospitalization days------1.017\*(1.007, 1.027)**Cause of death**GI11686.3351.818(0.944, 3.503)CVDs4896.5496.262\*(3.329, 11.779)Infections7235.4125.772\*(2.871, 11.602)Others2505.123------HD: hemodialysis; A-V: arteriovenous; EPO: erythropoietin; iPTH: intact parathyroid hormone; URR: urea reduction ratio; HBV: hepatitis B virus; HCV: hepatitis C virus; nPCR: normalized protein catabolic rate; TACurea: time-averaged concentration of urea\*p-value \< 0.05 in the univariate and multivariate-adjusted analyses. Table 3Clinical characteristics and outcomes associated factors of the study patients one year after the e-intervention.VariablesAll (n = 600)Non-e group (n = 300)e group (n = 300)p- value\^Frequency(%)/Mean ± SDFrequency(%)/Mean ± SDFrequency(%)/Mean ± SD**Outcome variablesHospitalization days (days/person-years)**1.66±9.083.39±12.770.00±0.00\<0.0001**Blood flow (cc/min)**287.39±39.31283.52±35.97291.08±41.990.0032**1-year all-cause mortality**Deaths13 (2.17)13 (4.33)0 (0.0)\<0.0001Survivors909 (97.5)287 (95.67)300 (100.0)**Physiological and biochemical variables**Albumin (g/dL)3.94±0.333.9±0.343.97±0.320.0041Pre-HD creatinine (mg/dL)10.76±2.4810.73±2.5410.78±2.440.733nPCR (g/kg/day)1.28±0.431.28±0.431.28±0.440.8284TACurea (mg/dL)41.87±11.5442.2±12.341.55±10.790.569Potassium (meq/L)4.93±0.764.93±0.774.94±0.750.7899Kt/V1.51±0.351.51±0.421.5±0.260.9566URR0.77±0.060.76±0.060.78±0.06\<0.0001Hematocrit (%)31.88±4.132.05±4.2631.72±3.940.6287Iron administration by veinNo463 (78.88)236 (82.23)227 (75.67)0.0509Yes124 (21.12)51 (17.77)73 (24.33)Monthly EPO usage (1000U/month)\*16 (10,22)16 (8,20)16 (12, 22)0.0979Calcium (mg/dL)9.76±0.999.82±1.019.71±0.960.2305Phosphate (mg/dL)4.9±1.494.89±1.574.91±1.420.8149iPTH (ng/mL)\*181.5 (62.1, 455.2)178.2 (53.4, 441.5)188.1 (71.7, 478.25)0.6106Total cholesterol (mg/dL)169.69±36.21168.94±35.75170.37±36.660.6157Glucose (mg/dL)\*96.0 (84.0, 128.0)97 (85, 129)94 (82, 127)0.2219Cardiothoracic ratio0.49±0.060.50±0.070.48±0.06\<0.0001e group: e-intervention group; non-e group: non-e-intervention group; HD: hemodialysis; nPCR: normalized protein catabolic rate; TACurea: time-averaged concentration of urea; URR: urea reduction ratio; EPO: erythropoietin; iPTH: intact parathyroid hormone.\*The variables with skew distribution were presented as median (1st-quartile, 3rd-quartile) and tested with Mann--Whitney U-test accordingly.\^The p-value was calculated by multiple regression models while adjusted by age, gender, and HD duration. Figure 1Survival functions Kaplan-Meier survival analysis in the 600 patients according to e-intervention or not showed four-year survival curve and number at risk table.

Discussion {#Sec5}
==========

Currently, the effects and potential benefits of e-intervention application in a health care system are a popular area of research. In 1977, Pollak *et al*. proposed that the objectives of adopting a new record system, such as an online computerized data handling system, to treat patients with renal diseases were: improving the decision-making processes, monitoring the quality of medical care, analyzing the data easily and rapidly, and serving as a useful new teaching model^[@CR10]^. In the past two decades, many systematic reviews have reported the positive effects of e-interventions^[@CR10]--[@CR12]^. Chaudhry *et al*. reported that electronic information systems enhance the quality of medical care by increasing the compliance of medical guidelines, strengthening the monitoring of medical practices, and reducing medical errors^[@CR13]^. Regarding to improving the quality of medical care, the main benefit of these systems is the decreased use of unnecessary medical resources. The main purpose of this study was to assess the effects of e-interventions on the quality of medical care and determine its potential benefits in patient data management in hospitals. Therefore, the two study groups were matched to improve comparability. Of the 1,208 patients in the database, a total of 932 eligible patients were included in the study after excluding cases with a HD duration \< 1 year. The eligible patients were individually matched for sex, age, HD duration, diabetes mellitus (DM), and hypertension, and finally 600 matched patients were evaluated in this study. The Student *t* test and chi-squared test revealed that the 932 eligible patients and the final 600 matched patients did not exhibit significant differences in their age, sex, hypertension, DM, and HD duration (*p* \> 0.05).

After applying electronic information technology to HD patient care, Pollak *et al*. observed that the mortality rate and hospital admission frequency of HD patients decreased considerably, particularly after the third year of system application^[@CR14]^. In the current study, the e-intervention group had a higher 4-year survival rate (84.67%) than the non-e-intervention group (80.33%). The multivariate Cox regression analysis showed that the e-intervention was one of the determining factors for the 4-year all-cause mortality rate. Furthermore, our results demonstrated that the e-intervention reduced the annual number of hospitalization days at 1-year post e-intervention. Moreover, e-intervention systems facilitate patient medical care. Pollak *et al*. indicated that the system could assist physicians to adjust patients' dry weight to prevent dialysis hypotension. The e-intervention systems enable rapid data review, thus enabling physicians and other health care professionals to perform adequate adjustments in medication prescriptions and medical orders^[@CR11]^. Furthermore, the systems provide the data associated with anemia to physicians and help them in adjusting the erythropoietin dosage and providing timely prescription of iron supply^[@CR12]^. In the present study, the e-intervention and non-e-intervention groups differed significantly in their 2-year all-cause mortality rates but not in their 4-year all-cause mortality rates. The e-intervention exerted short-term effects on outcomes during the first 2 years of application, demonstrating the multi-factorial nature of HD patients' prognosis. We applied generalized estimating equation to examine the effects of time-dependent variables, including the albumin, hematocrit, and phosphate level, on the patient outcomes and observed that the non-e-intervention group had a higher mortality rate than the e-intervention group (HR = 3.039; 95% CI = 1.737\~5.314). The e-intervention may exert independent effects beyond the pathways of time-dependent indicators on the mortality rates.

In addition to the e-intervention group, patients with relatively lower education level, unmarried, those with lower pre-HD creatinine levels, and those with higher sugar levels a higher 4-year all-cause mortality rate. Marriage was a protective factor for the 4-year all-cause mortality rate in this study patients. This finding is consistent with the findings of a previous study that applied the Social Adaptability Index in the dialysis population^[@CR15]^. Regarding the co~~-~~morbidities, Lorch *et al*. demonstrated that co~~-~~morbid conditions are major determinants of outcomes^[@CR12]^. Lower pre-HD serum creatinine levels associated with poor nutritional status have been evidenced as predictors of HD patients outcomes^[@CR16],\ [@CR17]^. In addition, high fasting glucose levels indicate poor sugar control in patients. The Choices for Healthy Outcomes in Caring for ESRD study showed that compared with arteriovenous fistula, the double lumen catheters were associated with increased degree of inflammation and higher mortality in incident HD patients^[@CR18]^. However, this finding was not observed in our study. We analyzed the principal diagnoses for patient's hospitalization during the first year of study and observed that infectious diseases (32.3%), cardiovascular or cerebrovascular diseases (21.3%), vascular access-associated disorders (18.3%), gastrointestinal disorders (15.9%), and others (12.2%) were associated with higher mortality rates in HD patients.

According to the data obtained before the e-intervention (Table [1](#Tab1){ref-type="table"}) and the outcomes at 1-year post e-intervention (Table [3](#Tab3){ref-type="table"}), the e-intervention group had a relatively higher URR, higher albumin levels, a lower cardiothoracic ratio^[@CR19]^, and a higher HD blood flow rate than the non-e-intervention group. Studies have reported that vascular access type associated with the HD blood flow rate influences the mortality in HD patients^[@CR20],\ [@CR21]^. However, a Japanese study suggested that a low HD blood flow rate may benefit the survival rates in their population^[@CR22]^. By contrast, the Dialysis Outcomes and Practice Patterns Study in Japan reported that patients with a lower HD blood flow rate (\<180 mL/min) had a higher mortality rate than the patients in the reference group with a relatively higher HD blood flow rate (180--210 mL/min)^[@CR23]^. Furthermore, Malaysian study showed that a higher HD blood flow rate is associated with a higher quality of life^[@CR24]^. A high HD blood flow rate may be attributed to the effective maintenance of the vascular access. Moreover, adequate HD blood flow rates can lead to adequate clearance, which is demonstrated by an increased Kt/V and URR^[@CR23]^. We performed Cox regression analysis for the 4-year all-cause mortality rates based on the biophysiological indicators measured 1-year post e-intervention. The HD blood flow rates were negatively associated with 4-year all-cause mortality rates (HR = 0.989, 95% CI = 0.984\~0.993), but did not exhibit significant results in the multivariate-adjusted analysis. Therefore, additional studies are warranted to elucidate the causal relationship between the HD blood flow rate and mortality rate.

The present study has numerous limitations. First, this study has a retrospective design, and cases with missing medical data and records were excluded. Therefore, the number of cases was reduced, which might have affected the integrity of the study results. Second, we intended to analyze the effects of e-interventions, therefore, the two study groups were matched for sex, age, HD duration, DM, and hypertension and the complicated cases were excluded. Therefore, the mortality rate and hospitalization frequency of the study patients were lower than those of the other studies in Taiwan^[@CR25],\ [@CR26]^. The distribution of the causes of ESRD was also different compared with other studies in Taiwan^[@CR25]^. Therefore, the predictors, such as serum phosphate and albumin levels, were closer to their normal ranges in the study patients and did not demonstrate a significant association with the mortality rates. Third, patients in the two study groups were from different hospital branches, and therefore some innate differences may have existed. Although the data were adjusted in the statistical analysis, interference effects cannot be completely ruled out. Fourth, the current health care system in Taiwan is a single-payer compulsory social insurance plan. Some prospective payment system policy interventions, including global budget, and pay-for-performance, were introduced during 2004--2005. Therefore, the data prior to 2005 were not included to avoid such historic effects on the results. Finally, because of the constant changes in the health care environment and health policies, the present results can only reflect the effects of the e-intervention during the specific study period and of the unique electronic information systems of the research institutes involved in the present study.

Conclusion {#Sec6}
==========

Due to the rapid advances in medical technology and increasing attention on health and medical effectiveness, the objective of HD treatment has gradually changed from the passive replacement kidney functions to the active reduction of complications and improvement in discomfort during HD. HD is expected to not only prolong life but also improve the quality of life. The e-intervention adopted for HD care in the present study showed promising results. The e-intervention group had a significantly higher HD blood flow rate, fewer hospitalization days, and a relatively lower 4-year all-cause mortality rate than the non-e-intervention group.

The implementation of e-interventions is a current trend in medical management to simplify medical-related processes and save medical resources^[@CR27]^. The use of an e-intervention to analyze and monitor medical processes can also help to provide safer medical services. However, e-interventions require substantial investments in hardware and software. In addition, medical personnel require education and training to appropriately operate these systems. Although e-interventions improved patient outcomes in the present study, additional studies are required to evaluate the cost effectiveness of such e-interventions.

Methods {#Sec7}
=======

Study patients and interventions {#Sec8}
--------------------------------

This retrospective was conducted using the clinical data abstracted from the Chang Gung Memorial Hospital (CGMH) information system. We evaluated the effectiveness of a quality improvement intervention by introducing an integrated information system for HD patient care. Although the analysis was performed using a prospective method, the nature and protocol of this study were reviewed and approved by the Institutional Review Board (IRB) of CGMH. The IRB provided an exemption certificate for this review (99--2617B). Therefore, written or verbal informed consent was not required from the study patients. All research methods in this study were performed in accordance with the approved guidelines.

The patients who received regular HD at any of the three CGMHs (Taoyuan, Taipei, and Linkou) in March 2007 were included in this study. Of the 1,208 HD patients, 276 were excluded due to one of the following reasons: (1) receiving regular HD for \< 1 year; (2) history of hospitalization within 1 year before March 2007; (3) receiving HD less than three times a week between March 2006 and February 2011; (4) receiving any alterations of the vascular access between March 2006 and February 2011; and (5) receiving HD at a different institution between March 2006 and February 2011. The remaining 932 HD patients were divided into the e-intervention group (patients who received HD at Taoyuan CGMH and were started on e-intervention from March 2007) and the non-e-intervention group (patients who received HD at Linkou CGMH and Taipei CGMH and did not receive e-intervention from March 2007) according to each patient's medical care settings. After matching for sex, age ± 3 years, HD duration, DM and hypertension, a total of 600 HD patients (300 patients each in the e-intervention and non-e-intervention groups) were recruited. Figure [2](#Fig2){ref-type="fig"} shows the consort diagram of the study patients.Figure 2The consort diagram of study samples.

The e-intervention involved the use of the HD electronic information management system of CGMH. It applied electronic information technology and integrated information from the HD patient information system, physician order entry system, and nursing system. It had access to the existing patient medical data system which provided medical records of all patients in CGMH. The e-intervention created a platform to share information with practitioners and patients and provide assisted patient-centered medical care. When a HD patient was admitted to the HD room, a code reader would record patient's identity and bed number and link with results from an electronic body weighing machine. The pre-dialysis preparation, including dialyzer, dialysate, and heparinization preparations, was performed by a technician according to the data present in the electronic information system. After starting the HD process, the ultrafiltration volume setting was established on the basis of the dry weight and measured body weight data in the electronic information system. During HD, patient data including blood pressure, body temperature, blood flow rate, dialysate flow rate and vascular access pressure, were recorded automatically and uploaded into the electronic information system. The HD nurses were informed by an e-alert system if any abnormality was detected. The system also provided physicians' orders to the HD nurses, who could promptly perform medical practices accordingly. Nearly twenty software interfaces in the electronic information system, including medical records, physicians' orders, medication data, medical devices, medical materials, HD schedules, HD indicators, data statistics, pricing, administrative affairs, and staff's duty scheduling, facilitated healthcare management. The major objectives of the e-intervention were to: (1) improve the efficiency of the medical care protocol by shortening the prescription time, prompting laboratory reports, and accelerating the acquisition of imaging information (electronic retrieval system for X ray images); (2) reduce the workload of medical personnel, including saving time on laboratory data retrieval, prompt prescription of medications on-line, and providing an expert assistance platform to assess the comprehensiveness of the patient data; (3) enhance the accuracy of medical processes including scheduling, prescriptions, laboratory reports, and medical records; and (4) increase patient safety and medical care quality through information integration. The patients in the e-intervention group were managed by the HD electronic information management system and the conventional patient medical data system. The patients in the non-e-intervention group were managed by their physicians and nurses using traditional paper-driven systems and conventional patient medical data systems. Figure [3](#Fig3){ref-type="fig"} presents a detailed description of the e-intervention and non-e-intervention group.Figure 3The architecture of the information systems utilized in this study.

Data collection {#Sec9}
---------------

The basic demographic variables and clinical data, including age, sex, education levels, occupation, marital status, HD duration, causes of ESRD (including chronic glomerulonephritis, DM, hypertension, and other chronic conditions), and history of diseases and health conditions (including hepatitis B virus, hepatitis C virus (HCV), vascular access types, DM, hypertension, and body mass index^[@CR28]^), of HD patients were assessed in March 2007 using a questionnaire and confirmed with a medical chart review. In addition, physiological and biochemical variables (including the daily amount of urine, dialyzer surface area, albumin, pre-HD creatinine, normalized protein catabolic rate^[@CR29]^, time-averaged concentration of blood urea nitrogen^[@CR30]^, potassium levels, Kt/V^[@CR31]^, URR, haematocrit levels, monthly erythropoietin usage, calcium, phosphate levels, intact parathyroid hormone, total cholesterol, cardiothoracic ratio, and iron supply) before the e-intervention (in February 2007) and at 1-year post e-intervention (in March 2008) were obtained. Intravenous of iron administration was prescribed to patients according to the protocol of the CGMH HD room: hematocrit \< 28%, transferrin saturation \< 20% and ferritin level \< 200 μg/mL, patients were intravenously administered with 1 g of Sucrofer^®^ (iron sucrose complex 2%, 20 mg Fe per mL, 5 mL per amp), divided to 10 times and was given one time a week for 10 weeks. During the 4-year follow-up period until February 2011, outcome variables, including total length of hospitalization and 4-year all-cause mortality rate were measured. Figure [4](#Fig4){ref-type="fig"} presents a detailed description of the time study schedule.Figure 4The time regimens of the study groups classified by e-intervention.

Statistical analysis {#Sec10}
--------------------

Numerical and categorical variables are presented as means ± standard deviations, and frequencies and percentages, respectively. The independent sample *t* test was used to compare the means of continuous variables and normally distributed data; otherwise, the Mann Whitney U test was used. The chi-squared test was used to compare the differences between categorical variables. A Cox regression model was used to determine the strength of the associations between the study groups and 4-year all-cause mortality, after examining (and adjusting for) the effects from other selected variables. A *p* value of \<0.1 was pre-determined as the multivariable model selection criteria among variables with *p* \< 0.05 in the univariate analysis after considering the effects of co-linearity among candidate variables. The results are expressed as multivariate-adjusted HR and corresponding 95% CIs. In stratified analysis, the causes of ESRD and the vascular access types were further categorized separately into groups and visualized using bar charts. Cumulative survival curves as a function of time were constructed using the Kaplan Meier approach, and the log rank test was conducted to determine their statistical significance. SAS software version 9.30 (Cary, NC, USA) was used for all statistical analyses in this study.
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